Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis
Abstract Background Interstitial lung diseases (ILDs) are associated with a high burden of disease. However, data on the prognostic impact of comorbidities and comorbidity-related pharmaceutical treatments in patients with various ILDs remain sparse. Methods Using longitudinal claims data from a Ger...
Main Authors: | Larissa Schwarzkopf, Sabine Witt, Julia Waelscher, Markus Polke, Michael Kreuter |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-018-0769-0 |
Similar Items
-
Cost drivers in the pharmacological treatment of interstitial lung disease
by: Phillen Nozibuyiso Maqhuzu, et al.
Published: (2021-08-01) -
Determinants of health-related quality of life decline in interstitial lung disease
by: Phillen Nozibuyiso Maqhuzu, et al.
Published: (2020-10-01) -
Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis
by: Julia Wälscher, et al.
Published: (2020-03-01) -
Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age
by: Xiaolei Tang, et al.
Published: (2020-01-01) -
Docetaxel‐induced interstitial lung disease among patients with breast cancer: a case series and review of literature
by: Sanjeewa Malinda Hettiarachchi, et al.
Published: (2021-07-01)